Legend Biotech Corporation has announced the appointment of Peter Salovey, Ph.D., as Lead Independent Director, effective June 5, 2025. Dr. Salovey, President Emeritus of Yale University, has been serving as an independent director on the company's Board since August 2024. In his new role, he will act as a key liaison among the Board, management, and shareholders.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.